 |
Prevail Therapeutics
Last updated: July 31, 2024
Jonathan Silverstein, Founder
USA | Funding: $129M (+)
Website: https://www.prevailtherapeutics.com/
Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease and other neurodegenerative diseases.
Website: https://www.prevailtherapeutics.com/
Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease and other neurodegenerative diseases.
